FCM
Farallon Capital Management Portfolio holdings
AUM
$21.3B
This Quarter Return
+13.51%
1 Year Return
+23.12%
3 Year Return
+87.19%
5 Year Return
+183.94%
10 Year Return
+836.54%
AUM
$14.1B
AUM Growth
+$14.1B
(+13%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
7.19%
Top 10 Holdings %
Top 10 Hldgs %
32.58%
Holding
150
New
30
Increased
52
Reduced
24
Closed
23
Top Buys
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$498M |
| 2 |
Boston Scientific
BSX
|
$316M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$208M |
| 4 |
Hilton Worldwide
HLT
|
$132M |
| 5 |
New York Times
NYT
|
$127M |
Top Sells
| 1 |
IAC Inc
IAC
|
$456M |
| 2 |
WUBA
58.COM INC
WUBA
|
$268M |
| 3 |
Salesforce
CRM
|
$208M |
| 4 |
Qiagen
QGEN
|
$123M |
| 5 |
CZR
Caesars Entertainment Corporation
CZR
|
$97.2M |
Sector Composition
| 1 | Healthcare | 41.8% |
| 2 | Communication Services | 18.01% |
| 3 | Technology | 8.41% |
| 4 | Financials | 7.57% |
| 5 | Industrials | 5.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
IQVIA
IQV
$32.4B
| $556M | 3.85% | 3,526,636 -269,394 | -7% | -$42.5M |
|
|
2
Alphabet (Google) Class C
GOOG
$2.58T
| $533M | 3.69% | 362,629 +141,579 | +64% | +$208M |
|
|
IMMU
3
DELISTED
Immunomedics Inc
IMMU
| $498M | 3.45% | +5,860,000 | New | +$498M |
|
4
Thermo Fisher Scientific
TMO
$186B
| $484M | 3.35% | 1,095,578 +26,073 | +2% | +$11.5M |
|
5
Fidelity National Information Services
FIS
$36.5B
| $466M | 3.22% | 3,162,858 -427,270 | -12% | -$62.9M |
|
6
Charter Communications
CHTR
$36.3B
| $458M | 3.17% | 733,191 -21,824 | -3% | -$13.6M |
|
7
T-Mobile US
TMUS
$284B
| $416M | 2.88% | 3,636,981 +179,350 | +5% | +$20.5M |
|
8
Centene
CNC
$14.3B
| $411M | 2.84% | 7,050,000 +50,000 | +0.7% | +$2.92M |
|
9
Meta Platforms (Facebook)
META
$1.86T
| $404M | 2.79% | 1,542,045 +183,551 | +14% | +$48.1M |
|
10
AbbVie
ABBV
$372B
| $372M | 2.57% | 4,250,000 +100,000 | +2% | +$8.76M |
|
11
Aon
AON
$79.1B
| $362M | 2.51% | 1,756,344 +35,846 | +2% | +$7.4M |
|
12
Visa
V
$683B
| $343M | 2.37% | 1,716,704 -82,669 | -5% | -$16.5M |
|
13
Elevance Health
ELV
$71.8B
| $342M | 2.37% | 1,275,000 +25,000 | +2% | +$6.71M |
|
14
Wabtec
WAB
$33.1B
| $337M | 2.33% | 5,439,551 +1,114,190 | +26% | +$68.9M |
|
15
Microsoft
MSFT
$3.77T
| $324M | 2.24% | 1,540,978 +12,779 | +0.8% | +$2.69M |
|
|
16
Boston Scientific
BSX
$156B
| $316M | 2.19% | +8,275,919 | New | +$316M |
|
|
17
New York Times
NYT
$9.74B
| $304M | 2.1% | 7,106,042 +2,968,500 | +72% | +$127M |
|
|
INFO
18
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $299M | 2.07% | 3,812,944 -97,080 | -2% | -$7.62M |
|
|
XLRN
19
DELISTED
Acceleron Pharma Inc.
XLRN
| $293M | 2.02% | 2,600,000 +500,000 | +24% | +$56.3M |
|
20
Sherwin-Williams
SHW
$91.2B
| $283M | 1.96% | 405,786 -42,201 | -9% | -$29.4M |
|
|
TIF
21
DELISTED
Tiffany & Co.
TIF
| $265M | 1.83% | 2,287,000 +759,302 | +50% | +$88M |
|
22
Exelixis
EXEL
$10.1B
| $263M | 1.82% | 10,750,000 +500,000 | +5% | +$12.2M |
|
23
Bristol-Myers Squibb
BMY
$96B
| $226M | 1.56% | 3,750,000 +125,000 | +3% | +$7.54M |
|
24
Palo Alto Networks
PANW
$127B
| $217M | 1.5% | 887,892 +35,787 | +4% | +$8.76M |
|
25
New Oriental
EDU
$7.85B
| $205M | 1.42% | 1,368,778 +737,778 | +117% | +$110M |
|